Redcare Pharmacy NV (RDC.DE)

EUR 139.9

(-3.38%)

Long Term Debt Summary of Redcare Pharmacy NV

Redcare Pharmacy NV's latest annual long term debt in 2023 was 236.04 Million EUR , down -4.69% from previous year.
Redcare Pharmacy NV's latest quarterly long term debt in 2024 Q2 was 266.8 Million EUR , up 0.12% from previous quarter.
Redcare Pharmacy NV reported annual long term debt of 247.65 Million EUR in 2022, up 7.66% from previous year.
Redcare Pharmacy NV reported annual long term debt of 230.02 Million EUR in 2021, up 601.09% from previous year.
Redcare Pharmacy NV reported quarterly long term debt of 234.81 Million EUR for 2024 Q1, up 14.91% from previous quarter.
Redcare Pharmacy NV reported quarterly long term debt of 249.21 Million EUR for 2023 Q1, up 0.63% from previous quarter.

Annual Long Term Debt Chart of Redcare Pharmacy NV (2023 - 2013)

Historical Annual Long Term Debt of Redcare Pharmacy NV (2023 - 2013)

Year	Long Term Debt	Long Term Debt Growth
2023	236.04 Million EUR	-4.69%
2022	247.65 Million EUR	7.66%
2021	230.02 Million EUR	601.09%
2020	32.81 Million EUR	-75.05%
2019	131.51 Million EUR	81.62%
2018	72.41 Million EUR	2151.59%
2017	3.21 Million EUR	862.87%
2016	334 Thousand EUR	-98.24%
2015	19 Million EUR	0.0%
2014	- EUR	0.0%
2013	- EUR	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q2	266.8 Million EUR	0.12%
2024 Q1	234.81 Million EUR	14.91%
2023 Q1	249.21 Million EUR	0.63%
2023 Q2	247.62 Million EUR	-0.64%
2023 Q4	236.04 Million EUR	0.28%
2023 FY	236.04 Million EUR	-4.69%
2023 Q3	235.39 Million EUR	-4.94%
2022 Q4	247.65 Million EUR	-7.31%
2022 Q1	231.86 Million EUR	0.8%
2022 Q2	261.91 Million EUR	12.96%
2022 FY	247.65 Million EUR	7.66%
2022 Q3	267.17 Million EUR	2.01%
2021 Q4	230.02 Million EUR	-8.12%
2021 Q3	250.35 Million EUR	0.02%
2021 Q2	250.28 Million EUR	0.11%
2021 Q1	250.01 Million EUR	662.0%
2021 FY	230.02 Million EUR	601.09%
2020 FY	32.81 Million EUR	-75.05%
2020 Q4	32.81 Million EUR	-79.53%
2020 Q3	160.3 Million EUR	0.53%
2020 Q2	159.45 Million EUR	-1.93%
2020 Q1	162.6 Million EUR	23.64%
2019 Q3	128.9 Million EUR	1.17%
2019 Q4	131.51 Million EUR	2.02%
2019 FY	131.51 Million EUR	81.62%
2019 Q1	72.76 Million EUR	0.49%
2019 Q2	127.41 Million EUR	75.1%
2018 Q1	- EUR	-100.0%
2018 FY	72.41 Million EUR	2151.59%
2018 Q4	72.41 Million EUR	0.0%
2018 Q3	- EUR	0.0%
2018 Q2	- EUR	0.0%
2017 Q3	- EUR	0.0%
2017 Q2	- EUR	0.0%
2017 Q4	3.21 Million EUR	0.0%
2017 FY	3.21 Million EUR	862.87%
2017 Q1	- EUR	-100.0%
2016 Q2	19.71 Million EUR	0.0%
2016 Q1	- EUR	-100.0%
2016 FY	334 Thousand EUR	-98.24%
2016 Q4	334 Thousand EUR	-98.34%
2016 Q3	20.07 Million EUR	1.81%
2015 Q1	- EUR	0.0%
2015 Q4	19 Million EUR	0.0%
2015 FY	19 Million EUR	0.0%
2014 FY	- EUR	0.0%
2013 FY	- EUR	0.0%

Peer Long Term Debt Comparison of Redcare Pharmacy NV

Name	Long Term Debt	Long Term Debt Difference
Newron Pharmaceuticals S.p.A.	25.76 Million EUR	-816.128%